Raymond James Financial’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$526K Buy
53,109
+4,189
+9% +$51.6K ﹤0.01% 4514
2026
Q2
$645K Buy
48,920
+6,082
+14% +$75.6K ﹤0.01% 4327
2026
Q1
$485K Buy
42,838
+19,807
+86% +$218K ﹤0.01% 4360
2025
Q4
$184K Sell
23,031
-125,940
-85% -$2.94M ﹤0.01% 4814
2025
Q3
$7.13M Buy
148,971
+65,579
+79% +$1.46M ﹤0.01% 2195
2025
Q2
$1.04M Buy
83,392
+65,170
+358% +$938K ﹤0.01% 3558
2025
Q1
$317K Buy
18,222
+7,875
+76% +$234K ﹤0.01% 4193
2024
Q4
$394K Hold
10,347
– – ﹤0.01% 4040

Other funds holding KRRO

Raymond James Financial's KRRO Position: Q3 2026 in Review

Raymond James Financial increased its Korro Bio (KRRO) stake by 8.6% in Q3 2026, buying an estimated $51.6K and bringing the position to 53,109 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Raymond James Financial first reported a position in KRRO in Q4 2024 and has held it in 8 quarters since. The position peaked at $7.13M in Q3 2025. 105 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • Raymond James Financial held 53,109 shares of Korro Bio worth $526K as of Q3 2026.
  • Raymond James Financial bought 4,189 Korro Bio shares in Q3 2026, an estimated $51.6K.
  • Korro Bio made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4514 holding.
  • Raymond James Financial first reported a position in Korro Bio in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Korro Bio position peaked at $7.13M in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.